معرفی
Jun Chung is an Associate Professor in the Department of Pathology at Stony Brook University's Renaissance School of Medicine. He holds affiliations as a Consultant in Tumor Biology at Biogen IDEC, Inc. (2007–present) and previously held academic positions at Louisiana State University and the University of Oklahoma Health Sciences Center.
- Education: B.S. in Biochemistry (Yonsei University, 1991), M.S. in Genetics and Cell Biology (University of Minnesota, 1994), PhD in Molecular Cell Biology (Washington University School of Medicine, 1999)
Dr. Chung's research focuses on developing therapeutics and diagnostics for breast cancers, particularly Triple Negative Breast Cancers (TNBCs). His work investigates integrin beta4 signaling in tumor invasion/metastasis and the role of tumor-suppressing micro-RNAs in TNBC progression. Current projects involve chemical modification of micro-RNAs to enhance therapeutic efficacy and delivery.
His recent publications highlight trends in TNBC therapy, integrin biology, microRNA modulation, and exosome-based diagnostics. Key subfields include Integrin-Src-Met Signaling, miR-489 Mimics, ARRDC3 Epigenetics, and Extracellular Vesicle Sorting in metastatic contexts.
Dr. Chung's laboratory offers PhD/postdoctoral opportunities in TNBC research. He has served in leadership roles such as Director of the Breast Cancer Focus Group at Feist-Weiller Cancer Center (2012–2013) and maintains collaborations in tumor biology.
